Erythema leprosum - After treatment of Lepromatous Leprosy;Erythema leprosum - Nach Therapie einer lepromatösen Lepra

JDDG - Journal of the German Society of Dermatology

Volumn 8, Issue 6, 2010, Pages 450-453

  Eickelmann, Mareike ^a   Steinhoff, Martin ^a   Metze, Dieter ^a   Tomimori Yamashita, Jane ^b   Sunderkötter, Cord ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Drug therapy; Erythema nodosum; Leprosy; Liprosy reaction; Mycobacterium leprae

Indexed keywords

CLOFAZIMINE; DAPSONE; GLUCOCORTICOID; PREDNISOLONE; RIFAMPICIN; THALIDOMIDE;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; ERYTHEMA NODOSUM LEPROSUM; FEMALE; GLOMERULONEPHRITIS; HUMAN; IRIDOCYCLITIS; LEPROMATOUS LEPROSY; MYCOBACTERIUM LEPRAE; NEURITIS; POLYARTHRITIS; WORLD HEALTH ORGANIZATION;

ADULT; ANTI-INFLAMMATORY AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG ERUPTIONS; ERYTHEMA NODOSUM; FEMALE; HUMANS; LEPROSTATIC AGENTS; LEPROSY, LEPROMATOUS; MEDICATION ADHERENCE; PREDNISOLONE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 77953142561     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2009.07294.x     Document Type: Article

References (10)

1. Abulafia J, Vignale RA. Leprosy: accessory immune system as effector of infectious, metabolic, and immunologic reactions. Int J Dermatol 2001 40 : 673 687.
2. Maeda SM, Rotta O, Michalany NS, Camargo ZP, Sunderkotter C, Tomimori-Yamashita J. Comparison between anti-PGL-I serology and Mitsuda reaction: clinical reading, microscopic findings and immunohi-stochemical analysis. Lepr Rev 2003 74 : 263 274.
3. Sunderkötter C, Essig A, Gärtner B. Hautinfektionen. In : Marre M, Trautmann: Klinische Infektiologie. 2. Aufl.
4. Lockwood DN, Sinha HH. Pregnancy and leprosy: a comprehensive literature review. Int J Lepr Other Mycobact Dis 1999 67 : 6 12.
5. Kumar B, Dogra S, Kaur I. Epidemiological characteristics of leprosy reactions: 15 years experience from north India. Int J Lepr Other Mycobact Dis 2004 72 : 125 133.
6. Murphy GF, Sanchez NP, Flynn TC, Sanchez JL, Mihm MC, Jr., Soter NA. Erythema nodosum leprosum: nature and extent of the cutaneous microvascular alterations. J Am Acad Dermatol 1986 14 : 59 69.
7. Ridley DS, Rea TH, McAdam KP. The histology of erythema nodosum leprosum. Variant forms in New Guineans and other ethnic groups. Lepr Rev 1981 52 : 65 78.
8. Modlin RL, Gebhard JF, Taylor CR, Rea TH. In situ characterization of T lymphocyte subsets in the reactional states of leprosy. Clin Exp Immunol 1983 53 : 17 24.
9. Sunderkotter CH, Tomimori-Yamashita J, Nix V, Maeda SM, Sindrilaru A, Mariano M, Sorg C, Roth J. High expression of myeloid-related proteins 8 and 14 characterizes an inflammatorily active but ineffective response of macrophages during leprosy. Immunology 2004 111 : 472 480.
10. Faber WR, Jensema AJ, Goldschmidt WF. Treatment of recurrent erythema nodosum leprosum with infliximab. N Engl J Med 2006 355 : 739.